Alamar Biosciences, Inc. · 3 months ago
Regional Business Manager - Chicago, Minneapolis, or Indianapolis
Alamar Biosciences is focused on enabling scientific discoveries that lead to clinical outcomes for patients. They are seeking a Regional Business Manager to develop and execute commercial strategies within the Midwest US territory, building customer relationships and supporting the company's global expansion.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Develop a territory and account-based sales plan for the territory
Execute the plan for the territory to meet or exceed company goals
Deliver presentations on the Alamar technology to customers in seminars and meetings
Consult customers on the value of Alamar technology for precision proteomics to ensure the delivery of an exceptional customer experience
Partner across the company to communicate the needs of customers to drive future product developments and market expansion
Manage and drive the sales process within a complex sales environment
Utilize, update and manage the CRM system
Effectively manage and deliver an accurate forecast for the sales territory
Drive prospecting and develop new leads in the region to expand the pipeline, customer base and open up new markets
Support the expansion of the commercial organization as needed to meet the company goals
Qualification
Required
Bachelors degree in the Life Sciences or related field
5+ years or equivalent of proven life science capital sales experience and success
Deep knowledge of biomarker discovery and life science markets
Highly adaptable and independent professional
Strong desire to build customer relationships for long term engagement
Ideally Based in Chicago, Minneapolis, or Indianapolis
Benefits
Commission
Equity
Benefits
Company
Alamar Biosciences, Inc.
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels.
Funding
Current Stage
Growth StageTotal Funding
$282MKey Investors
Alzheimer's Drug Discovery FoundationSands Capital VenturesSherpa Healthcare Partners
2026-01-11Convertible Note· $50M
2025-01-08Grant· $10M
2024-02-26Series C· $128M
Recent News
2026-01-14
Company data provided by crunchbase